Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bevacizumab(Avastin) Induced Hypertension and Correlation With Tumor Response, a Chart Review

NCT00322725 is registered in ClinicalTrials.gov with University of New Mexico as lead sponsor.

NCT NCT00322725
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00322725 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bevacizumab(Avastin) Induced Hypertension and Correlation With Tumor Response, a Chart Review
Lead sponsor
University of New Mexico
Phase
Observational
Overall status
Terminated
Start date
February 28, 2006
Completion date
April 30, 2009
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer